Enacts new GS 90-12.8 allowing licensed physicians to prescribe a therapeutic drug approved by the US Food and Drug Administration for off-label use to a patient for at-home, early-stage outpatient or hospital inpatient treatment of coronavirus infections causing respiratory syndrome-related illnesses. Specifies that a physician acting in good faith under this statute does not solely constitute immoral or dishonorable conduct or unprofessional conduct. Provides that the statute does not grant greater liability protection to a physician than provided for in other State law.

Requires the NC Medical Board to adopt temporary rules to implement the act.

Above provisions are effective October 1, 2022.

Appropriates $10,000 from the General Fund to the Department of Health and Human Services to publicize the effects of this act to health care providers. Effective July 1, 2022.